Kelli McFarland White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kelli McFarland White has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Jianmin Cui
Department of Biomedical Engineering, Center for the Investigation of Membrane Excitability Diseases, Washington University in St. Louis, MO 63130, USA
3 shared publications Jingyi Shi
Department of Biomedical Engineering, Center for the Investigation of Membrane Excitability Disorders, and Cardiac Bioelectricity and Arrhythmia Center, Washington University, St. Louis, MO 63130, USA
3 shared publications- Po Wei Kang
Department of Biomedical Engineering, Washington University in St.Louis, St. Louis, MO 63130, USA
3 shared publications Lu Zhao
Department of Biomedical Engineering, Center for the Investigation of Membrane Excitability Disorders, and Cardiac Bioelectricity and Arrhythmia Center, Washington University, St. Louis, MO 63130, USA
2 shared publications- Alex Dou
Department of Molecular Physiology and Biophysics, University of Iowa (C.J.C., C.E.A., A.D., J.D.G., L.G., S.G.T., D.T.I., B.L., C.A.A.).
1 shared publication Alex K. Dou
Department of Biomedical Engineering, Center for the Investigation of Membrane Excitability Disorders, and Cardiac Bioelectricity, and Arrhythmia Center, Washington University, St. Louis, MO 63130, USA
1 shared publication
Latest Publications
- Open Access
- 22 July 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (29) , eabo3625
Electro-mechanical coupling of KCNQ channels is a target of epilepsy-associated mutations and retigabine
KCNQ2 and KCNQ3 form the M-channels that are important in regulating neuronal excitability. Inherited mutations that alter voltage-dependent gating of M-channels are associated with neonatal epilepsy. In the homolog KCNQ1 channel, two steps of voltage sensor activation lead to two functionally distinct open states, the intermediate-open (IO) and activated-open (AO), which define the gating, physiological, and pharmacological properties of KCNQ1. However, whether the M-channel shares the same mechanism is unclear. Here, we show that KCNQ2 and KCNQ3 feature only a single conductive AO state but with a conserved mechanism for the electro-mechanical (E-M) coupling between voltage sensor activation and pore opening. We identified some epilepsy-linked mutations in KCNQ2 and KCNQ3 that disrupt E-M coupling. The antiepileptic drug retigabine rescued KCNQ3 currents that were abolished by a mutation disrupting E-M coupling, suggesting that modulating the E-M coupling in KCNQ channels presents a potential strategy for antiepileptic therapy.
- 22 July 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (29) , eabo3625
Open AccessElectro-mechanical coupling of KCNQ channels is a target of epilepsy-associated mutations and retigabine
KCNQ2 and KCNQ3 form the M-channels that are important in regulating neuronal excitability. Inherited mutations that alter voltage-dependent gating of M-channels are associated with neonatal epilepsy. In the homolog KCNQ1 channel, two steps of voltage sensor activation lead to two functionally distinct open states, the intermediate-open (IO) and activated-open (AO), which define the gating, physiological, and pharmacological properties of KCNQ1. However, whether the M-channel shares the same mechanism is unclear. Here, we show that KCNQ2 and KCNQ3 feature only a single conductive AO state but with a conserved mechanism for the electro-mechanical (E-M) coupling between voltage sensor activation and pore opening. We identified some epilepsy-linked mutations in KCNQ2 and KCNQ3 that disrupt E-M coupling. The antiepileptic drug retigabine rescued KCNQ3 currents that were abolished by a mutation disrupting E-M coupling, suggesting that modulating the E-M coupling in KCNQ channels presents a potential strategy for antiepileptic therapy.
- 14 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (20)
Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects
Significance: C28, a chemical compound identified by computational screening, selectively facilitates voltage-dependent activation of a cardiac potassium ion channel, I Ks . This compound reverses drug-induced prolongation of the electric signals across the cardiac cell membrane known as action potentials (APs) but minimally affects the normal AP at the same dosage. This outcome supports a computational prediction that enhancing voltage-dependent activation of I Ks could be a potential therapy for AP prolongation. This therapy would increase the safety and expand the therapeutic efficacy of many currently approved drugs that induce AP prolongation, which can trigger life-threatening cardiac arrhythmias.
- 14 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (20)
Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects
Significance: C28, a chemical compound identified by computational screening, selectively facilitates voltage-dependent activation of a cardiac potassium ion channel, I Ks . This compound reverses drug-induced prolongation of the electric signals across the cardiac cell membrane known as action potentials (APs) but minimally affects the normal AP at the same dosage. This outcome supports a computational prediction that enhancing voltage-dependent activation of I Ks could be a potential therapy for AP prolongation. This therapy would increase the safety and expand the therapeutic efficacy of many currently approved drugs that induce AP prolongation, which can trigger life-threatening cardiac arrhythmias.
- Open Access
- 11 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (50) , eabd6798
Calmodulin acts as a state-dependent switch to control a cardiac potassium channel opening
Calmodulin controls KCNQ1 potassium channel pore opening by competing with PIP2in the KCNQ1 voltage-sensing domain.
- 11 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (50) , eabd6798
Open AccessCalmodulin acts as a state-dependent switch to control a cardiac potassium channel opening
Calmodulin controls KCNQ1 potassium channel pore opening by competing with PIP2in the KCNQ1 voltage-sensing domain.